Erratum (DOI:10.1016/j.hrthm.2008.01.020);Recurrent intrauterine fetal loss due to near absence of HERG: Clinical and functional characterization of a homozygous nonsense HERG Q1070X mutation

Heart Rhythm

Volumn 5, Issue 4, 2008, Pages 553-561

  Bhuiyan, Zahurul A ^a   Momenah, Tarek S ^b   Gong, Qiuming ^d   Amin, Ahmad S ^a,c   Ghamdi, Saleh Al ^b   Carvalho, Julene S ^e,f   Homfray, Tessa ^e   Mannens, Marcel M A M ^a   Zhou, Zhengfeng ^d   Wilde, Arthur A M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Prince Sultan Cardiac Centre   (Saudi Arabia)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Electrophysiology; HERG; Long QT syndrome; Nonsense mediated decay; Sudden cardiac death

Indexed keywords

ION CHANNEL; POTASSIUM CHANNEL HERG;

ADULT; ARAB; ARTICLE; BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CELL MEMBRANE; CONSANGUINITY; DISEASE SEVERITY; FAMILY; FEMALE; FETUS; FETUS WASTAGE; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC TRANSFECTION; HAPLOTYPE; HEART ARRHYTHMIA; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MICROSATELLITE MARKER; MUTANT; NONSENSE MUTATION; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SIBLING; THIRD TRIMESTER PREGNANCY; WESTERN BLOTTING;

EID: 40849097481     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.03.033     Document Type: Erratum

References (29)

1. Crotti L., Stramba-Badiale M., Pedrazzini M., et al. Prevalence of the long QT syndrome. (abstr). Circulation 112 Suppl II (2005) 3097
2. Wilde A.A., and Bezzina C.R. Genetics of cardiac arrhythmias. Heart 91 (2005) 1352-1358
3. Curran M.E., Splawski I., Timothy K.W., et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80 (1995) 795-803
4. Sanguinetti M.C., Curran M.E., Spector P.S., et al. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A 93 (1996) 2208-2212
5. Kr channels minimally comprise hERG 1a and 1b subunits. J Biol Chem 279 (2004) 44690-44694
6. Roden D.M., and Balser J.R. A plethora of mechanisms in the HERG-related long-QT syndrome: genetics meets electrophysiology. Cardiovasc Res 44 (1999) 242-246
7. Anderson C.L., Delisle B.P., Anson B.D., et al. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation 113 (2006) 365-373
8. Gong Q., Zhang L., Vincent G.M., et al. Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long QT syndrome. Circulation 116 (2007) 17-24
9. Piippo K., Laitinen P., Swan H., et al. Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. J Am Coll Cardiol 35 (2000) 1919-1925
10. Johnson Jr. W.H., Yang P., Yang T., et al. Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome. Pediatr Res 53 (2003) 744-748
11. Hoorntje T., Alders M., van Tintelen P., et al. Homozygous premature truncation of the HERG protein: the human HERG knockout. Circulation 100 (1999) 1264-1267
12. Itoh T., Tanaka T., Nagai R., et al. Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome. Hum Genet 102 (1998) 435-439
13. Johns D.C., Nuss H.B., and Marbán E. Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs. J Biol Chem 272 (1997) 31598-31603
14. Choe C.U., Schulze-Bahr E., Neu A., et al. C-terminal HERG (LQT2) mutations disrupt IKr channel regulation through 14-3-3epsilon. Hum Mol Genet 15 (2006) 2888-2902
15. Kagan A., Melman Y.F., Krumerman A., et al. 14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity. EMBO J 21 (2002) 1889-1898
16. Verkerk A.O., Wilders R., Schulze-Bahr E., et al. Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome. Cardiovasc Res 68 (2005) 441-453
17. Gong Q., Keeney D.R., Robinson J.C., et al. Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndrome. J Mol Cell Cardiol 37 (2004) 1225-1233
18. Zhou Z., Gong Q., Epstein M.L., et al. HERG channel dysfunction in human long QT syndrome: intracellular transport and functional defects. J Biol Chem 273 (1998) 21061-21066
19. Thomas D., Zhang W., Karle C.A., et al. Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A. J Biol Chem 274 (2005) 27457-27462
20. Frischmeyer P.A., and Dietz H.C. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 8 (1999) 1893-1900
21. Holbrook J.A., Neu-Yilik G., Hentze M.W., et al. Nonsense-mediated decay approaches the clinic. Nat Genet 36 (2004) 801-808
22. Nagy E., and Maquat L.E. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 23 (1998) 198-199
23. Winston N.J., Johnson M.H., McConnell J.M., et al. Expression and role of the ether-a-go-go-related (MERG1A) potassium-channel protein during preimplantation mouse development. Biol Reprod 70 (2004) 1070-1079
24. Lees-Miller J.P., Guo J., Somers J.R., et al. Selective knockout of mouse ERG1 B potassium channel eliminates I(Kr) in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia. Mol Cell Biol 23 (2003) 1856-1862
25. Milan D.J., Peterson T.A., Ruskin J.N., et al. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107 (2003) 1355-1358
26. London B. A knockout may not always be a knockout. (letter). Circulation 102 (2000) E122
27. Linde L., Boelz S., Nissim-Rafinia M., et al. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J Clin Invest 117 (2007) 683-692
28. Kimura S., Ito K., Miyagi T., et al. A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy. Brain Dev 27 (2005) 400-405
29. Sangkuhl K., Schulz A., Rompler H., et al. Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo. Hum Mol Genet 13 (2004) 893-903